Surveillance of wildlife and livestock for novel and emerging coronaviruses

Information

  • Research Project
  • 10266305
  • ApplicationId
    10266305
  • Core Project Number
    R21AI162594
  • Full Project Number
    1R21AI162594-01
  • Serial Number
    162594
  • FOA Number
    PA-20-195
  • Sub Project Id
  • Project Start Date
    7/1/2021 - 4 years ago
  • Project End Date
    6/30/2023 - 2 years ago
  • Program Officer Name
    STEMMY, ERIK J
  • Budget Start Date
    7/1/2021 - 4 years ago
  • Budget End Date
    6/30/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    6/18/2021 - 4 years ago
Organizations

Surveillance of wildlife and livestock for novel and emerging coronaviruses

Project Summary There is an urgent need for coronavirus (CoV) surveillance in both wildlife and livestock. As seen repeatedly, CoVs have a propensity to jump species from their bat, rodent and avian reservoirs, often to intermediate species including livestock, before infecting humans. Our knowledge of North American CoVs in wildlife species is sparse and routine sequencing of livestock CoVs are limited. In our first aim, to detect and sequence coronaviruses in wildlife and livestock, we will utilize a pan-coronavirus RT-PCR to screen a unique sample set consisting of bats and wildlife rarely surveilled. The sample set is comprised of ~500 animals submitted to our veterinary diagnostic laboratory for rabies testing over a 12-month period and consists of pooled lung, spleen and intestine tissue homogenate. In parallel, we will screen food animal diagnostic submissions from animals with acute enteric and respiratory disease. Our second aim, to further characterize coronavirus genomes and characterize virus isolates, phylogenetic and recombination analysis will be performed with the assembled CoV genomes. Specifically, assembled genomes will be annotated and submitted to Genbank and made publicly available immediately. Phylogenetic analysis will determine if SARS-CoV-2, CoVs similar to SARS-CoV-2 or novel CoVs have emerged in non-human species. Recombination analysis will next be performed using SARS-CoV-2 and the assembled CoV genomes to determine if SARS-CoV-2 or related CoVs have undergone natural recombination and contributed genetic material to endemic CoV. Another component of this aim is to isolate and propagate the detected CoVs in cell culture. This latter aim is critical for further pathogenesis studies in the natural host and model organisms. This R21 exploratory project meets an urgent need for CoV surveillance at the human-animal interface, both in wildlife and livestock. Results from this study will identify emerging disease threats and develop critical tools, including sequences, detection methodology and cell culture adapted viruses that will enable further studies on possible zoonosis and enable preemptive action.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R21
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
    150000
  • Indirect Cost Amount
    72750
  • Total Cost
    222750
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    EARTH SCIENCES/RESOURCES
  • Funding ICs
    NIAID:222750\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SOUTH DAKOTA STATE UNIVERSITY
  • Organization Department
    VETERINARY SCIENCES
  • Organization DUNS
    929929743
  • Organization City
    BROOKINGS
  • Organization State
    SD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    570070001
  • Organization District
    UNITED STATES